Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data

Genome Biology

Volumn 13, Issue 12, 2012, Pages

  Parker, Matthew ^a   Chen, Xiang ^a   Bahrami, Armita ^a   Dalton, James ^a   Rusch, Michael ^a   Wu, Gang ^a   Easton, John ^a   Cheung, Nai Kong ^b   Dyer, Michael ^a   Mardis, Elaine R ^c,d   Wilson, Richard K ^c,d   Mullighan, Charles ^a   Gilbertson, Richard ^a   Baker, Suzanne J ^a   Zambetti, Gerard ^a   Ellison, David W ^a   Downing, James R ^a   Zhang, Jinghui ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BRAIN TUMOR; CHILD; CHILDHOOD CANCER; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA CONTENT; DNA DETERMINATION; DNA SEQUENCE; GENE DELETION; GENE INSERTION; GENE LOSS; GENE SEQUENCE; GENETIC GAIN; GENETIC VARIABILITY; GENOME ANALYSIS; GENOMIC INSTABILITY; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; SOLID TUMOR; TELOMERE; TELOMERE HOMEOSTASIS; TUMOR GENE; ADULT; CHEMISTRY; GENETICS; GENOMICS; NEOPLASM; PROCEDURES;

ADULT; CHILD; DNA, NEOPLASM; GENOMICS; HUMANS; NEOPLASMS; SEQUENCE ANALYSIS, DNA; TELOMERE;

EID: 84870677276     PISSN: None     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2012-13-12-r113     Document Type: Article

References (33)

1. Okuda K, Bardeguez A, Gardner JP, Rodriguez P, Ganesh V, Kimura M, Skurnick J, Awad G, Aviv A. Telomere length in the newborn. Pediatr Res 2002, 52:377-381. 10.1203/00006450-200209000-00012, 12193671.
2. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198. 10.1038/nature02118, 14608368.
3. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33:787-791. 10.1016/S0959-8049(97)00062-2, 9282118.
4. Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 1997, 6:921-926. 10.1093/hmg/6.6.921, 9175740.
5. Cesare AJ, Reddel RR. Telomere uncapping and alternative lengthening of telomeres. Mech Ageing Dev 2008, 129:99-108. 10.1016/j.mad.2007.11.006, 18215414.
6. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 1999, 59:4175-4179.
7. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002, 30:e47. 10.1093/nar/30.10.e47, 115301, 12000852.
8. O'Callaghan NJ, Fenech M. A quantitative PCR method for measuring absolute telomere length. Biol Proced Online 2011, 13:3. 10.1186/1480-9222-13-3, 3047434, 21369534.
9. Castle JC, Biery M, Bouzek H, Xie T, Chen R, Misura K, Jackson S, Armour CD, Johnson JM, Rohl CA, Raymond CK. DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing. BMC Genomics 2010, 11:244. 10.1186/1471-2164-11-244, 2867831, 20398377.
10. Downing JR, Wilson RK, Zhang J, Mardis ER, Pui CH, Ding L, Ley TJ, Evans WE. The Pediatric Cancer Genome Project. Nat Genet 2012, 44:4.
11. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds SB, Ulyanov A, Becksfort J, Gupta P, Huether R, Kriwacki RW, Parker M, McGoldrick DJ, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012, 481:157-163. 10.1038/nature10725, 3267575, 22237106.
12. Cheung NK, Zhang J, Lu C, Parker M, Bahrami A, Tickoo SK, Heguy A, Pappo AS, Federico S, Dalton J, Cheung IY, Ding L, Fulton R, Wang J, Chen X, Becksfort J, Wu J, Billups CA, Ellison D, Mardis ER, Wilson RK, Downing JR, Dyer MA, St Jude Children's Research Hospital-Washington University Pediatric Cancer Genome P Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA 2012, 307:1062-1071. 10.1001/jama.2012.228, 3527076, 22416102, St Jude Children's Research Hospital-Washington University Pediatric Cancer Genome P.
13. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Zhang J, Baker SJ, St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome P Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 2012, 44:251-253. 10.1038/ng.1102, 3288377, 22286216, St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome P.
14. Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, Ulyanov A, Wu G, Wilson M, Wang J, Brennan R, Rusch M, Manning AL, Ma J, Easton J, Shurtleff S, Mullighan C, Pounds S, Mukatira S, Gupta P, Neale G, Zhao D, Lu C, Fulton RS, Fulton LL, Hong X, Dooling DJ, Ochoa K, Naeve C, Dyson NJ, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 2012, 481:329-334. 3289956, 22237022.
15. Cancer Genome Atlas Research N Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068. 10.1038/nature07385, 2671642, 18772890, Cancer Genome Atlas Research N.
16. Cancer Genome Atlas Research N Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. 10.1038/nature10166, 3163504, 21720365, Cancer Genome Atlas Research N.
17. Tabori U, Dome JS. Telomere biology of pediatric cancer. Cancer Invest 2007, 25:197-208. 10.1080/07357900701208683, 17530490.
18. Malaska J, Sklenickova M, Krejci K, Fajkusova L, Bajer M, Hrstkova H, Fajkus J. Telomerase activity and expression and telomere analysis in situ in the course of treatment of childhood leukemias. Blood Cells Mol Dis 2000, 26:534-539. 10.1006/bcmd.2000.0332, 11112386.
19. Engelhardt M, Ozkaynak MF, Drullinsky P, Sandoval C, Tugal O, Jayabose S, Moore MA. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 1998, 12:13-24. 10.1038/sj.leu.2400889, 9436916.
20. Else T, Giordano TJ, Hammer GD. Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma. J Clin Endocrinol Metab 2008, 93:1442-1449. 10.1210/jc.2007-1840, 18198226.
21. Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo J, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu D, Pollock RE, Reddel RR. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 2005, 11:217-225.
22. Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB, Dome JS. Telomerase expression predicts unfavorable outcome in osteosarcoma. J Clin Oncol 2004, 22:3790-3797. 10.1200/JCO.2004.03.043, 15365076.
23. Ulaner GA, Huang HY, Otero J, Zhao Z, Ben-Porat L, Satagopan JM, Gorlick R, Meyers P, Healey JH, Huvos AG, Hoffman AR, Ladanyi M. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res 2003, 63:1759-1763.
24. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 1992, 83:159-164. 10.1111/j.1349-7006.1992.tb00081.x, 1555997.
25. Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR, Royds JA. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 2003, 361:836-838. 10.1016/S0140-6736(03)12681-5, 12642053.
26. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood 2003, 102:2321-2333. 10.1182/blood-2002-12-3817, 12791663.
27. O'Callaghan N, Dhillon V, Thomas P, Fenech M. A quantitative real-time PCR method for absolute telomere length. Biotechniques 2008, 44:807-809. 10.2144/000112761, 18476834.
28. Edmonson MN, Zhang J, Yan C, Finney RP, Meerzaman DM, Buetow KH. Bambino: a variant detector and alignment viewer for next-generation sequencing data in the SAM/BAM format. Bioinformatics 2011, 27:865-866. 10.1093/bioinformatics/btr032, 3051333, 21278191.
29. Wang J, Mullighan CG, Easton J, Roberts S, Heatley SL, Ma J, Rusch MC, Chen K, Harris CC, Ding L, Holmfeldt L, Payne-Turner D, Fan X, Wei L, Zhao D, Obenauer JC, Naeve C, Mardis ER, Wilson RK, Downing JR, Zhang J. CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods 2011, 8:652-654. 10.1038/nmeth.1628, 3527068, 21666668.
30. DAC: St. Jude Children's Hospital - Washington University Cancer Genome Project. , https://www.ebi.ac.uk/ega/dacs/EGAC00001000044
31. Pediatric Cancer Genome Project: Explore. , http://explore.pediatriccancergenomeproject.org/dataAccess
32. Aird D, Ross MG, Chen WS, Danielsson M, Fennell T, Russ C, Jaffe DB, Nusbaum C, Gnirke A. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol 2011, 12:R18. 10.1186/gb-2011-12-2-r18, 3188800, 21338519.
33. Yeung KY, Fraley C, Murua A, Raftery AE, Ruzzo WL. Model-based clustering and data transformations for gene expression data. Bioinformatics 2001, 17:977-987. 10.1093/bioinformatics/17.10.977, 11673243.